The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer. 2016

Shou-Hua Wang, and Wen-Jie Zhang, and Xiao-Cai Wu, and Ming-Zhe Weng, and Ming-Di Zhang, and Qiang Cai, and Di Zhou, and Jian-Dong Wang, and Zhi-Wei Quan
Department of General Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Gallbladder carcinoma (GBC) is an aggressive neoplasm, and the treatment options for advanced GBC are limited. Recently, long non-coding RNAs (lncRNAs) have emerged as new gene regulators and prognostic markers in several cancers. In this study, we found that metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) expression was up-regulated in GBC tissues (P < 0.05). Luciferase reporter assays and RNA pull down assays showed that MALAT1 is a target of miR-363-3p. Real-time quantitative PCR and Western blot analysis indicated that MALAT1 regulated Myeloid cell leukaemia-1 (MCL-1) expression as a competing endogenous RNA (ceRNA) for miR-363-3p in GBC cells. Furthermore, MALAT1 silencing decreased GBC cell proliferation and the S phase cell population and induced apoptosis in vitro. In vivo, tumour volumes were significantly decreased in the MALAT1 silencing group compared with those in the control group. These data demonstrated that the MALAT1/miR-363-3p/MCL-1 regulatory pathway controls the progression of GBC. Inhibition of MALAT1 expression may be to a novel therapeutic strategy for gallbladder cancer.

UI MeSH Term Description Entries
D008297 Male Males
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D005706 Gallbladder Neoplasms Tumors or cancer of the gallbladder. Cancer of Gallbladder,Gallbladder Cancer,Cancer of the Gallbladder,Gall Bladder Cancer,Neoplasms, Gallbladder,Bladder Cancer, Gall,Bladder Cancers, Gall,Cancer, Gall Bladder,Cancer, Gallbladder,Cancers, Gall Bladder,Cancers, Gallbladder,Gall Bladder Cancers,Gallbladder Cancers,Gallbladder Neoplasm,Neoplasm, Gallbladder
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Shou-Hua Wang, and Wen-Jie Zhang, and Xiao-Cai Wu, and Ming-Zhe Weng, and Ming-Di Zhang, and Qiang Cai, and Di Zhou, and Jian-Dong Wang, and Zhi-Wei Quan
November 2019, Cell proliferation,
Shou-Hua Wang, and Wen-Jie Zhang, and Xiao-Cai Wu, and Ming-Zhe Weng, and Ming-Di Zhang, and Qiang Cai, and Di Zhou, and Jian-Dong Wang, and Zhi-Wei Quan
January 2019, Journal of biological regulators and homeostatic agents,
Shou-Hua Wang, and Wen-Jie Zhang, and Xiao-Cai Wu, and Ming-Zhe Weng, and Ming-Di Zhang, and Qiang Cai, and Di Zhou, and Jian-Dong Wang, and Zhi-Wei Quan
November 2015, Oncotarget,
Shou-Hua Wang, and Wen-Jie Zhang, and Xiao-Cai Wu, and Ming-Zhe Weng, and Ming-Di Zhang, and Qiang Cai, and Di Zhou, and Jian-Dong Wang, and Zhi-Wei Quan
November 2019, Journal of cellular and molecular medicine,
Shou-Hua Wang, and Wen-Jie Zhang, and Xiao-Cai Wu, and Ming-Zhe Weng, and Ming-Di Zhang, and Qiang Cai, and Di Zhou, and Jian-Dong Wang, and Zhi-Wei Quan
August 2021, Vascular pharmacology,
Shou-Hua Wang, and Wen-Jie Zhang, and Xiao-Cai Wu, and Ming-Zhe Weng, and Ming-Di Zhang, and Qiang Cai, and Di Zhou, and Jian-Dong Wang, and Zhi-Wei Quan
February 2018, Bioscience reports,
Shou-Hua Wang, and Wen-Jie Zhang, and Xiao-Cai Wu, and Ming-Zhe Weng, and Ming-Di Zhang, and Qiang Cai, and Di Zhou, and Jian-Dong Wang, and Zhi-Wei Quan
January 2019, American journal of translational research,
Shou-Hua Wang, and Wen-Jie Zhang, and Xiao-Cai Wu, and Ming-Zhe Weng, and Ming-Di Zhang, and Qiang Cai, and Di Zhou, and Jian-Dong Wang, and Zhi-Wei Quan
July 2017, Scientific reports,
Shou-Hua Wang, and Wen-Jie Zhang, and Xiao-Cai Wu, and Ming-Zhe Weng, and Ming-Di Zhang, and Qiang Cai, and Di Zhou, and Jian-Dong Wang, and Zhi-Wei Quan
January 2017, International journal of medical sciences,
Shou-Hua Wang, and Wen-Jie Zhang, and Xiao-Cai Wu, and Ming-Zhe Weng, and Ming-Di Zhang, and Qiang Cai, and Di Zhou, and Jian-Dong Wang, and Zhi-Wei Quan
October 2021, Biochemical genetics,
Copied contents to your clipboard!